Back to the main directory
Event / Equity
- Espresso | Oxurion | Buy | Strong cash position by Kepler Cheuvreux
- Espresso | VAT Group | Buy | Orders, sales, EBITDA in line, EPS miss by Kepler Cheuvreux
- Espresso | Atlantia | Hold | Lower Q4 results, deleveraging and capital rotation ahead by Kepler Cheuvreux
- Espresso | Shop Apotheke | Buy | EU challenges Germany on Rx pricing what this implies for SAE by Kepler Cheuvreux
- Espresso | Azimut | Buy | Upgrade to Buy on positive message and new commission scheme by Kepler Cheuvreux
- Espresso | Vonovia | Buy | Still an attractive growth story by Kepler Cheuvreux
- Espresso | Accell Group | Buy | Core business beat for FY 2018 by Kepler Cheuvreux
- Espresso | Eurazeo | Buy | FY 2018 results review by Kepler Cheuvreux
- Espresso | CGG | Buy | Operational roughly in line, higher impairment by Kepler Cheuvreux
- Espresso | Hugo Boss | Hold | Pros and cons from the conference call by Kepler Cheuvreux
- Espresso | Boliden | Buy | CMD expect focus on capex, electrification, and growth projects by Kepler Cheuvreux
- Espresso | Deutsche Bank | Reduce | Big effort, meagre outcome by Kepler Cheuvreux
- Espresso | Rubis | Buy | Closing Kenolkobil deal by Kepler Cheuvreux
- Espresso | BW Offshore | Buy | Adding oil exposure by Kepler Cheuvreux
- Espresso | Belimo | Hold | Good results, higher-than-expected dividend, positive 2019 outlook by Kepler Cheuvreux
- Espresso | Sensorion | Buy | Sensorion secures its cash position by Kepler Cheuvreux
- Espresso | Anima | Buy | Small outflows in February due to low margin insurance policies by Kepler Cheuvreux
- Espresso | CNH Industrial | Buy | North America ag equipment retail sales in February by Kepler Cheuvreux
- Espresso | Aryzta | Reduce | H1 beat, reiterates guidance, expect estimates to nudge up, stock rally by Kepler Cheuvreux
- Espresso | Fermentalg | Buy | 2018 results: no surprises by Kepler Cheuvreux
- Espresso | Kongsberg Gruppen | Buy | Order bonanza kicking off by Kepler Cheuvreux
- Espresso | ENAV | Hold | Better Q4, outlook confirmed, update on performance targets soon by Kepler Cheuvreux
- Espresso | CIR | Buy | Lower net result in Q4, moving towards the merger with Cofide by Kepler Cheuvreux
- Espresso | Biophytis | Hold | FY results: no surprises by Kepler Cheuvreux
- Espresso | PureCircle | Hold | Growth momentum sustained by Kepler Cheuvreux